Dialysis: Glycated albumin or HbA 1c in dialysis patients with diabetes?

Nature Reviews Nephrology

Volumn 7, Issue 9, 2011, Pages 490-492

  Biesenbach, Georg ^a   Pohanka, Erich ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DIALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEALTH PRACTITIONER; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SURVIVAL;

BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 80052273923     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2011.95     Document Type: Review

References (10)

1. Freedman, B. I. et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin. J. Am. Soc. Nephrol. 6, 1635-1643 (2011).
2. Inaba, M. et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. J. Am. Soc. Nephrol. 18, 896-903 (2007). (Pubitemid 46434506)
3. Shurraw, S., Majumdar, S. R., Thadhani, R., Wiebe, N. & Tonelli, M. Glycemic control and the risk of death in 1484 patients receiving maintenance hemodialysis. Am. J. Kidney Dis. 55, 875-884 (2010).
4. Vlassara, H. & Palace, M. R. Diabetes and advanced glycation endproducts. J. Intern. Med. 251, 87-101 (2002). (Pubitemid 34146691)
5. Kalantar-Zadeh, K. et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 30, 1049-1055 (2007). (Pubitemid 46684623)
6. Uzu, T. et al. Target for glycemic control in type 2 diabetic patients on hemodialysis: Effects of anemia and erythropoietin injection on hemoglobin A1c. Ther. Apher. Dial. 13, 89-94 (2009).
7. Nagayama, H. et al. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Biomed. Pharmacother. 63, 236-240 (2009).
8. Okada, T. et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. Intern. Med. 46, 807-814 (2007). (Pubitemid 47261661)
9. Dawnay, A., Farrington, K., Castledine, C., van Schalkwyk, D. & Warwick, G. UK Renal Registry 12th Annual Report (December 2009): Chapter 10: Biochemistry profile of patients receiving dialysis in the UK in 2008: National and centre-specific analyses. Nephron Clin. Pract. 115 (Suppl. 1), c187-c237 (2010).
10. Fukuoka, K. et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology 13, 278-283 (2008). (Pubitemid 351668328)